PAT - Seen from an Automation and Information Solutions Provider
|
|
- Juliana Jefferson
- 5 years ago
- Views:
Transcription
1 PAT - Seen from an Automation and Information Solutions Provider Alberto Rossi Rockwell Automation 09. October 2007 Copyright 2007 Rockwell Automation, Inc. All rights reserved. 1
2 Agenda Rockwell Automation At-a-Glance Industry Drivers PAT Strategies Case studies Summary 2
3 Overview - Focused on Life Sciences Over $1.0B installed base in Life Sciences Active industry leadership: PDA, JETT, ISPE, ISA88, ISA95, ISA99, MESA, WBF Installed at 95% of the Fortune 50 pharmaceutical companies 75% of top 150 Life Sciences OEMs Strengths in Plant Floor Control and Information Management offer RA solutions 3
4 Agenda Rockwell Automation At-a-Glance Industry Drivers PAT Strategies Case studies Summary 4
5 Industry Acceptance: Major Milestones Industry Acceptance FDA Introducti on User consortium established to drive PAT standard 50% of leaders initiate PAT programs Pfizer - $10M 250 programs FDA is involved in 12 Projects and there are 30 Letters of Intent Today Embedded methodology for all new projects Initial Results of Pilot Prg. PAT Standard Defined Full Scale Program Implementati on The FDA would like PAT to become commonplace not to be an initiative. John E. Simmons PhD US Food and Drug Administration 5
6 Manufacturing Excellence PAT Discrepant Product High quality, with high scrap & rework Old Paradigm: Increase product testing to improve product quality Result: Better product quality, but higher scrap and product rework rates, extend production time. New Paradigm: Increase process quality to improve product quality. Result: Better product quality and lower scrap and product rework rates, reduce production time. Process Quality Source: IBM BCS 2005 End Product Quality The PAT Paradigm Shift 6
7 Manufacturing Excellence - FDA s View Best practices in quality management methods, particularly in other high-tech industries, have undergone significant progress since 1978 when the CGMP regulations were last updated. The FDA wants to ensure its regulatory practices encourage similar progress... -FDA 7
8 Agenda Rockwell Automation At-a-Glance Industry Drivers PAT Strategies Case studies Summary 8
9 Pharmaceutical CGMPs for the 21st Century: Encourage the early adoption of new technological advances by industry Facilitate industry application of modern quality management techniques, to all aspects of pharmaceutical production and quality assurance. Ensure that regulatory review, compliance, and inspection policies are based on state-of-the-art pharmaceutical science Enhance the consistency and coordination of FDA's business processes and regulatory policies concerning review and inspection activities Adopt a model that benefits FDA, the industry and the consumer Pharmaceutical CGMPS for the 21 st Century A Risk Based Approach Final Report
10 PAT Strategies Risk-Based Approach Control of Risk Critical Process Parameters Failure Analysis & Mgmt Assessing Patient Risk Risk of Non- Compliance Technology Transfer Process Understanding Scientific Understanding Causes of Variability Control of CPP s Predict Quality Attributes Regulatory Strategies Validation, Change Control, Equipment Qualification Real-Time Quality Assurance End Product Quality Real-Time Release In-Process Data Final Product Data Lab Data Material Attributes Lagged Quality By Inspection Real-Time Quality By Design 10
11 Paradigm Shift from Conventional to PAT Example: Oral Solid Dosage Manufacturing ventional Approach Lab-centric, offline testing of product quality End-of-phase quality testing reduces risk moving to next stage Quality by Inspection Raw Materials Dispensing Granulation Mixing / Compression / Milling Blending Drying / Coating Packaging Hold & Release 11
12 PAT Process Monitoring & Control Example: Oral Solid Dosage Manufacturing Measure Critical Parameter s Correct Process PAT Approach Online & at-line monitoring & control of CPP s Continuously test quality during phase eliminates risk moving to next stage Raw Materials Dispensing Granulation / Milling Mixing / Blending Drying Compression / Coating Packaging Quality by Design Real-Time Quality Assurance NIR Material Identification Power Consumption Granulation End Point On-line blend uniformity End Point Control Vision Particle Analyzer NIR Conformance Testing Acoustic Granulation End Point On-line vision particle size analysis NIR Core Potency NIR Coating Thickness Imaging of Blisters 12
13 Batch recording today Materials preparation Weighing, Preparing Dispensing, Mixing Instructions and verifications Equipment PLCs, Scada, DCs. Recipes, instructions, calibration schedules PM schedules, cleaning schedules, alarm lists, PV trend plots Manual operations, sampling, laboratory testing BMs, CMMs LIMs Operator instructions, activity verifications, recorded values, deviations, signatures Utilities reports, alarm lists, historion reports trends,... Utilities & environmental systems ( ie; WFI, air quality ) Paper Batch Record 13
14 ...Right First Time Manufacturing with EBR On-Line preparation instructions, verification, and materials reconciliation Equipment Operators Environment (e.g. sterile rooms) W&D Part11 EWI Warehouse PCS BMS Complete Electronic BATCH Record Electronic MASTER BATCH Record PAT PAT PAT LIMS Real Time Automation and Information Control and Decision Management LIMS Part11 Real time release 14
15 RA s vision for Electronic Batch Recording Potenti al Saving s EBR real time release EBR parametric release EBR review by exception EBR manual review Paper based systems Ticket system Paper on glass EBR High integration PAT - EBR Manufacturi ng Capability 15
16 Agenda Rockwell Automation At-a-Glance Industry Drivers PAT Strategies Case studies Summary 16
17 Case Study 1: PAT in a Solid Dosage Manufacturing Process Case Study #1 Process Raw Materials Dispensing and sieving Granulation and milling Mixing / Blending (actives & excipients) Drying Compression / coating Packaging Instrumentation NIR Mid-IR Raman UV-Vision Fluorescence Vision particle characterization Focused Beam Reflectance Measurement (FBRM) Particle Vision Microscopy Acoustic spectroscopy 17
18 API 1630nm Avicel 1425nm Lactose 1450nm Raw Chemicals: Raw Materials HE H7 Process Knowledge Mapping Through Multivariate Analysis H2 HB 8 x 63 = 504 kg Approx. 8 x 25 = 200 kg 8 x 31 = 248 kg Water/LOD BLENDING Case Study #1 0 testing~chem quality(e.g. ph,roi,ipt ) 1 usage~weight 2 power~time 3 energy to reach 55 C at exhaust 4 LOD 5 granulation yield data 6 blending yield data not numbered hold time Glidant deg C "wc deg C deg F deg F Lubricant /10/02 2:02:45 PM Min(s) 11/10/02 2:48:55 PM Water Water vessel Lot Number Air exhaust C FBD Supply Air Temperature FBD Supply Air Flow FBD Exhaust Air Temperatur FBD Supply Air Humidity - FBD Pre-Chill Air Temperat FBD DH Regen Temperature GRANULATION Standard deviation Resource (vessel) Id 2 8x % power Vibratory Separator Asset number Blend sample number 1 30Kg 1 10Kg 8x 36 kg 4 ø< 1mm ø> 1mm Impact Mill + 40 kg SIFTING 120 kg 156 kg 120 kg Granulator Fluidized Bed Dryer 3 Air 95 C High Flow = scfm Process Flow = scfm 960 kg DISPENSING, PRE-MIX GRANULATION DRYING 5 min (+0.5) min Max 4x (3+10+5s ) min SIFTING & SIZING 5 Hold Time < 1 month 1000 kg BLENDING 10±5 min 6 18
19 Data Mining Problem Data available from multiple sources/formats Electronic (time series, EBR, LIMS, spreadsheets, ) Paper (charts, reports) Expert knowledge Need: convert data into information For management For operators For automatic control Use data mining results to Design control improvements Real time decision making Case Study #1 19
20 Case Study - Goals Case Study #1 Apply the Feature selection Automatically rank all 140 parameters Use top three parameters to create an empirical model Achieve 0.9 or better correlation with filtered quality data Achieve 0.7 or better correlation with raw quality data Able to predict quality property to within 1 standard deviation Copyright 2005 Rockwell measurement Automation, Inc. All rights reserved. accuracy 20
21 Case Study - Results Case Study #1 Q-actual (blue) Q-predicted (red) Time Blue: standard deviation (measurement) Red: model prediction error Q-predicted Feature Selection - Empirical Model Time Q-actual 1-std Top three parameters used in the model One process parameter One environmental parameter One raw material parameter Model results available during initial stages of production Model result = additional valid measurement 0.9 or better correlation with filtered quality data 0.7 or better correlation with raw quality data 21
22 Summary of Case Study Results Case Study #1 Model prediction is feasible for this batch process Impressive modeling accuracy Determined list of ranked critical process parameters with respect to two key quality properties Next step: use the model (or the knowledge) during real time operation to reduce process variation 22
23 Case Study : RA Demonstration (Solution based on Industry Standards) Rockwell Automation has significantly complemented our point of view and added key manufacturing elements to our sciencebased approach for reducing revenue@risk, said Doug Dean, senior executive, Global Quality and Value-Driven Compliance, IBM Healthcare and Life Sciences. The Proof-of-Concept is the first demonstration of how complex solutions can be integrated with a compliance-centric architecture to transform a pharmaceutical organization s development and manufacturing processes. 23
24 Proof of Concept: IBM s Proof of Concept (PoC) Business goals Science (PAT) & Risk based approach in NPD, manufacturing, and supply chain mgmt. Preferred Technologies & Technology Asset Alignment Industrialization Processes & Collaboration Feedback loops from MFG to NPD Demonstrate end-to end business process management deployment Technology goals Demonstrate Technology Integration (Enterprise Application Integration, Web Services, plug n play Vendor SW, ) Platform to integrate unit and enable enterprise PAT Coexistence of Websphere & Netweaver Demonstrate key principles of Business Process Management, including process specification, process activation in runtime, process enforcement & compliance, Closed loop process management Demonstrate key principles of integrated security management 24
25 Agenda Rockwell Automation At-a-Glance Industry Drivers PAT Strategies Case studies Summary 25
26 Solutions for Manufacturing Competitiveness R&D Clinical Producti on From R&D thru Clinical to Commercial Manufacturing Knowledge Experience 26
27 Solutions for Manufacturing Competitiveness ERP Informatio n Strategy From R&D thru Clinical to Commercial Manufacturing Connect plant floor to business system Information Tactics Automatio n Data 27
28 Solutions for Manufacturing Competitiveness Continiou s Batch Discrete From R&D thru Clinical to Commercial Manufacturing Connect plant floor to business system API Intermediate Product One single platform for multiple disciplines 28
29 Solutions for Manufacturing Competitiveness Distributed From R&D thru Clinical to Commercial Manufacturing Centralized Connect plant floor to business system Standalone Unit Area Plant/Enterpri se One single platform for multiple disciplines Scalable from OEM to Enterprise solutions Standardize KPIs across the enterprise 29
30 Solutions for Manufacturing Competitiveness Level 4 Level 3 Level 2 Level 1 Business Logistic Plant production Scheduling, Shipping, Receiving, Inventory, etc.. Manufacturing Operations Management Dispatching, Detailed Production Scheduling, Production Tracking,... Continio us Control Batch Control Discre te Contro l From R&D thru Clinical to Commercial Manufacturing Connect plant floor to business system One single platform for multiple disciplines Scalable from OEM to Enterprise solutions Standardize KPIs across the enterprise Based on S88/S95 Level 0 30
31 PAT Solution Space Map Services Project Services Training Life-Cycle Network Asset Mgmt Compliance & Quality Partnerships IBM E+H Encompass Partners Others 31
32 Alberto Rossi Sr Consultant Copyright 2007 Rockwell Automation, Inc. All rights reserved. 32
Continuous Manufacturing
Continuous Manufacturing Continuous ing in the Industry Continuous processing has been adopted by the majority of process industries for the manufacturing of fluids (i.e. liquids and gasses) and solids
More informationApplication of PAT for Tablet Analysis. Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013
Application of PAT for Tablet Analysis Case examples from Novartis Lorenz Liesum, Lead PAT Hamburg, 19 th of April 2013 Agenda PAT@Novartis Organization Business Drivers and Cases NIR Spectroscopy for
More informationSiemens AG All rights reserved.
How to create a PAT data management platform to support Continuous Production 8th Annual PAT and QbD Conference, London, February 16 th, 2011 Jan Verelst Back in time Page 2 What caused this disaster?
More informationMES Middle Ages Evolution Space. Florian Seitz Werum Asia Support Centre
MES From Past to Present to Future 1 MES Middle Ages Evolution Space Florian Seitz Werum Asia Support Centre MES From Past to Present to Future 2 From Past to Present to Future Nokia 5100 iphone 5 15 years
More informationPreventing Errors with a Mobile MES
AADECA JORNADA TECNICA MES* EN INDUSTRIA FARMACEUTICA 14/05/2010 *MANUFACTURING ENTERPRISE SYSTEMS ISPE Preventing Errors with a Mobile MES Agenda Manufacturing Challenges - MES Benefits MES Systems Purpose
More informationThe Factory of the Future...is possible today?
The Factory of the Future...is possible today? Antonio Buendia, Head of Manufacturing Process Controls OSIsoft EMEA Users Conference, Prague, October 2015 Disclaimer "The information contained in this
More informationABB Industries PAT Validation
Alison Harrington ABB Industries PAT Validation ABB Industries - 1 - Topics PAT disciplines and framework FDA evolution PAT Regulatory Process Quality System Comparability Protocol Submission example Validation
More informationPQLI Engineering Controls and Automation Strategy
J Pharm Innov (2008) 3:88 94 DOI 10.1007/s12247-008-9031-5 PRODUCT QUALITY LIFECYCLE IMPLEMENTATION (PQLI) INNOVATIONS PQLI Engineering Controls and Automation Strategy Ray Bolton Stephen Tyler Published
More informationICH Q8/Q8(R)
Pharmaceutical Quality for the 21 st Century Temple University May 06, 2008 Joseph Famulare, Deputy Director FDA CDER Office of Compliance CDER Office of Compliance and the Critical Path Initiative Since
More informationCurrent Industry Practices in Manufacturing Process Validation. Russ Somma PhD
Russ Somma PhD The objectives for validation are: Demonstrate control over the process and finished product. Demonstrate that the process will consistently produce product which meets all specifications
More informationEnterprise PI Enabling an Integrated Manufacturing Landscape
Enterprise PI Enabling an Integrated Manufacturing Landscape Barry Higgins Janssen Biologics Ireland Copyright 2011, OSIsoft LLC. All rights Reserved. Agenda Background Enabling MES Introducing PI Asset
More informationLeveraging an EA for an Integrated Platform in Life Sciences. Cop yri g h t 2014 OSIso f t, LLC.
Leveraging an EA for an Integrated Platform in Life Sciences Presented by Axel Schnuetgen Business Overview Healthcare Corp Baxter BioScience Baxter Medical Products Baxter's BioScience business continues
More informationPAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland
PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec 2004 Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland cca@iol.ie 1 FDA Context 1) FDA 5-Part Strategic Plan Protect &
More informationPAT for the On-line Characterization of Continuous Manufacturing Systems
PAT for the On-line Characterization of Continuous Manufacturing Systems Thomas O Connor, Ph.D. Office of Pharmaceutical Science FDA/PQRI Conference: Innovation in Manufacturing and Regulatory Assessment
More informationSuccessful Introduction of PAT Requires a Strategy
OR AL SOLID DOSAGE CONTINUOUS MANUFACTURING TECHNOLOGIE S Successful Introduction of PAT Requires a Strategy By Dr. Hubertus Rehbaum, Pharma/Life Sciences Consultant F Dr. Hubertus Rehbaum or the past
More informationScientific and Regulatory Considerations for Continuous Manufacturing Implementation for Drug Product
Scientific and Regulatory Considerations for Continuous Manufacturing Implementation for Drug Product Arwa El Hagrasy, Ph.D. Quality Assessment Lead (Acting) Office of Process and Facilities OPQ/FDA PQRI
More informationIndustry Perspective on Manufacturing in Early Development
Industry Perspective on Manufacturing in Early Development IQ Workshop, Feb 4-5, 2014, Washington, D.C. Eric Schmitt AbbVie IQ Drug Product Manufacturing Working Group August 2012 issue of Pharmaceutical
More informationGMP Challenges to Global Pharma Companies
GMP Challenges to Global Pharma Companies Muralidhara B. Gavini, Ph.D. Senior Assistant Country Director India Mumbai Office, Office of International Programs Office of the Commissioner Food & Drug Administration
More informationT41 - Batch Management
T41 - Batch Management What s New and What s Next Agenda Batch and Sequencing Opportunities Modern Batch Differentiation Scalable Batch Solutions What s Next? 2 Batch and Sequencing Opportunities Distributed
More informationWhat is ISA-95? Industrial Best Practices of Manufacturing Information Technologies with ISA-95 Models
What is ISA-95? Industrial Best Practices of Manufacturing Information Technologies with ISA-95 Models Dennis Brandl, BR&L Consulting IEC65E/JWG5 Convener ISA 95 Editor 2008-05-19 Copyright 2008 BR&L Consulting
More informationYang Angela Liu, Ph.D. Pfizer Worldwide Research & Development Groton CT, USA
On the horizon: The integrated PAT control strategy for PCMM (portable, continuous, miniature, modular) - an agile development and manufacturing platform Yang Angela Liu, Ph.D. Pfizer Worldwide Research
More informationNovartis automation strategy: The Workcenter of the Future (WoF) Cop yri g h t 2014 OSIso f t, LLC.
Novartis automation strategy: The Workcenter of the Future (WoF) Presented by Antonio BUENDIA Cop yri g h t 2014 OSIso f t, LLC. Disclaimer "The information contained in this presentation belongs or has
More informationImplementation of PAT for Real Time Release Testing. Mark Smith Process Analytical Sciences Group Pfizer, Cork
Implementation of PAT for Real Time Release Testing Mark Smith Process Analytical Sciences Group Pfizer, Cork PAT at Pfizer A key enabler for transformational strategies and new quality paradigms 9 Delivering
More informationProcess Automation. Process Analytical Technology Executive Summary for the Life Sciences Industry
Automation Analytical Technology Executive Summary for the Life Sciences Industry Why ABB? A Quality by Design (QbD) approach using Analytical Technology (PAT) requires more than a collection of analyzers
More informationIntegrating OSIsoft PI System with syntq for High Performance, Low Maintenance PAT Method Integration
Integrating OSIsoft PI System with syntq for High Performance, Low Maintenance PAT Method Integration Presented by: Mairtin Martin Mc Gadsby Namara (J&J) Martin Gadsby (Optimal) 1 Overview Introduction
More informationIntegration and Connection Strategies to Maximize the Benefits from Your MES System
Integration and Connection Strategies to Maximize the Benefits from Your MES System Jerry Gonzalez Business Systems Manager B. Braun Medical Inc Baha Korkmaz, PMP. Senior VP Operations North America Baha.Korkmaz@esp.ie
More informationQuality by Design (QbD)
Evaluating the Critical Quality attributes & Critical Process Parameters-A Case Study-Tablets GMP International Workshop February 20/21, 2008 Mumbai, India Mukund Yelvigi Director, Therapeutic Area Management,
More informationMOISTURE CONTENT MEASUREMENT CASE STUDY
MOISTURE CONTENT MEASUREMENT CASE STUDY This case study is based on a large research-focused health care company with a long tradition in pharmaceutical production and diagnostics. The company was founded
More informationA Framework and Case Study for Implementing the New Process Validation Guidance
A Framework and Case Study for Implementing the New Process Validation Guidance Presented By Bikash Chatterjee President and Chief Technology Officer Pharmatech Associates Agenda Introduction Comparing
More informationImplementation of QBD for Analytical Methods - Session Introduction -
Implementation of QBD for Analytical Methods - Session Introduction - Sonja Sekulic January 24, 2014 Quality by Design (QbD) A Systematic Approach ICH Q8(R2) Product Profile Define quality target product
More informationPAT and Quality by Design exemplified in a Mock P2 submission for examplain tablets. Part 1: Concept and Principles Part 2: Mock P2 Submission
PAT and Quality by Design exemplified in a Mock P2 submission for examplain tablets Part 1: Concept and Principles Part 2: Mock P2 Submission 1 Part 1 Concept and Principles Introduction Rationale Concept
More informationThe Drug Industry at a Crossroad: PAT s Role
The Drug Industry at a Crossroad: PAT s Role The old paradigm must make way for the new; here s how it can happen. By Efraim Shek, Ph.D., Senior Vice President, Pharmaceutical Development, NeuroMolecular
More informationRockwell Software PharmaSuite A Key Ingredient to Build a Connected Enterprise
- 5058-CO900H Rockwell Software PharmaSuite A Key Ingredient to Build a Connected Enterprise PUBLIC 2 THE CONNECTED ENTERPRISE enhanced by the Internet of Things delivers transformational value in productivity
More informationHow to Identify Critical Quality Attributes and Critical Process Parameters
How to Identify Critical Quality Attributes and Critical Process Parameters Jennifer Maguire, Ph.D. Daniel Peng, Ph.D. Office of Process and Facility (OPF) OPQ/CDER/FDA FDA/PQRI 2 nd Conference North Bethesda,
More informationA Siemens Business MANUFACTURING INTELLIGENCE FOR LIFE SCIENCES
A Siemens Business MANUFACTURING INTELLIGENCE FOR LIFE SCIENCES Vision Manufacturing Intelligence for Life Sciences At Elan Software, we think, act and conduct business the way Life Science companies do.
More informationDigital Solutions for the Life Sciences Industry The connected product and manufacturing concept
Digital Solutions for the Life Sciences Industry The connected product and manufacturing concept Unrestricted Siemens AG 2017 Realize innovation. An introduction Andrew Whytock Vertical Pharma Competence
More informationConducting Supplier Audits: Ensure Validation Compliance
Conducting Supplier Audits: Ensure Validation Compliance Presented by: Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Outline Why
More informationImproved Time to Results in Life Sciences PharmaSuite
Improved Time to Results in Life Sciences PharmaSuite Mark Drochek Information Solutions Technical Consultant November 5, 2012 Business Pressures in Life Sciences Maximize productivity Minimize production
More information2014 Software Global Client Conference
Connect People, Process and Technology for Intelligent Operations Dr. Stuart Parker Director, Global Consulting Paul Feder Consulting Director Amount of Information Managers Receive that has no Value 0-30%
More informationNIRS, PAT, RTR testing EU experience and regulatory perspective
NIRS, PAT, RTR testing EU experience and regulatory perspective Heidelberg, Germany October 2013 European Compliance Academy (ECA) Overview of the presentation General considerations Cases submitted in
More informationPresented by Leif Poulsen Global Technology Partner, NNE Introduction to Automation & IT with focus on Competences DAu Seminar
Presented by Leif Poulsen Global Technology Partner, NNE Introduction to Automation & IT with focus on Competences DAu Seminar 2017-10-25 1 Agenda Automation & IT Organisation Automation & IT Services
More informationImplementing Continuous Pharmaceutical Manufacturing: An FDA Perspective
Implementing Continuous Pharmaceutical Manufacturing: An FDA Perspective Christina Capacci-Daniel, Ph.D. Acting Quality Assessment Lead / Consumer Safety Officer Division of Inspectional Assessment, Office
More informationManaging Quality in Pharmaceutical Industry Using Six Sigma. Edited by Mahmoud Farouk Moussa TQM, CSSBB, MBA
Managing Quality in Pharmaceutical Industry Using Six Sigma Edited by Mahmoud Farouk Moussa TQM, CSSBB, MBA Outlines Pharmaceutical Manufacturing Process and Drug Product Quality. Process Excellence Approach
More informationRobust and flexible processes with paperless manufacturing. Innovations for the pharmaceutical industry. usa.siemens.com/pharma
Robust and flexible processes with paperless manufacturing Innovations for the pharmaceutical industry usa.siemens.com/pharma A paperless recipe for pharmaceutical success Faced with growing cost pressures,
More informationStrategic Implantation of PAT : FDA Perspective
Strategic Implantation of PAT : FDA Perspective Moheb M. Nasr, Ph.D. CDER, FDA MOHEB.NASR@FDA.HHS.GOV IFPAC 2008 Strategic Implantation of PAT Baltimore, MD January 27, 2008 Outline The Desired State -
More informationControl Strategy. Implementation of ICH Q8, Q9, Q10
Implementation of ICH Q8, Q9, Q10 Control Strategy International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Introduction Structure of this session
More informationA Compilation of WHO GMP Audit Points
A Compilation of WHO GMP Audit Points Collected from WHOPIR of 28 companies Part III of VIII Current article Part III Production Prepared and Submitted By: Edited by : A. Jwalakanth B.Pharm, MBA (Aus)
More informationAudit Validation Programs Like a Champ (When your time is limited!!) Cathelene Compton 12 October 2017
Audit Validation Programs Like a Champ (When your time is limited!!) Cathelene Compton 12 October 2017 FDA 483 Observations 2 FDA 483 Observations 3 FDA 483 Observations 4 Auditing Validation How to cover
More informationContent PART I: ANDA Roadmap PART II: Understanding of CPPs & CQAs PART III: Scale-Up and Technology Transfer PART IV: Process Validation & Sampling 2
EMA, FDA- ANDA Readiness -OSD Generics Solution Post Formulation Development Horch Guo, May. 2016, Changzhou, China Hongxing.guo@yahoo.com Content PART I: ANDA Roadmap PART II: Understanding of CPPs &
More informationCHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE
CHALLENGES & OPPORTUNITIES OF ICHQ8 (PHARMACEUTICAL DEVELOPMENT) AN INDUSTRY PERSPECTIVE Paul Stott, PhD Head of US Product Development AstraZeneca ICH Quality Guidelines Workshop BioKorea 2007 Sept 13-14
More informationThe use of surrogates for dissolution testing for Immediate Release (IR) formulations, when is it feasible?
The use of surrogates for dissolution testing for Immediate Release (IR) formulations, when is it feasible? Limin Zhang (Bristol-Myers Squibb Company) Andre Hermans (Merck & Co., Inc.) 2017 M-CERSI Workshop
More informationSEEING THE FUTURE A REVIEW OF THE ISPE 2016 FACILITY OF THE FUTURE CONFERENCE. Phil McDuff VP Global Engineering Biogen
SEEING THE FUTURE A REVIEW OF THE ISPE 2016 FACILITY OF THE FUTURE CONFERENCE Phil McDuff VP Global Engineering Biogen Robert Chew President & CEO Commissioning Agents Inc. Jim McGlade Client Leader BHDP
More informationFacility and Equipment Maintenance
Facility and Equipment Maintenance Deborah L. Griffin Manager, Quality Assurance for Cellular Therapies Hillman Cancer Center University of Pittsburgh Cancer Institute University of Pittsburgh Medical
More informationPAT Initiative Pilot Project API Production. Gerhard Korb. Sanofi-Aventis Deutschland GmbH. Process Development Chemistry
Gerhard Korb Sanofi-Aventis Deutschland GmbH Process Development Chemistry Chemical & Particle Engineering Frankfurt Summary PAT Initiative Pilot Project API Production Tools - Definition Example Additional
More informationMANUFACTURING OPERATIONS MANAGEMENT MAKING SENSE OF THE MES LAYER
MANUFACTURING OPERATIONS MANAGEMENT MAKING SENSE OF THE MES LAYER Dennis Brandl www.brlconsulting.com BR&L Consulting, Inc. dnbrandl@brlconsulting.com 208 Townsend Ct, Suite 220 +1-919-852-5322 Cary, NC
More informationOnline Remote Monitoring (Internet of Things IoT) and enterprise software
F&B CUSTOMER DAY SURABAYA, SEPTEMBER 5, Digitalizing F&B processes Online Remote Monitoring (Internet of Things IoT) and enterprise software Ronald Lim, Control Technology business unit, Industrial Automation
More informationIntegrated Quality and Traceability
Integrated Quality and Traceability Siemens AG, Industry Sector IA AS MES Cargill Cargill is an international producer and marketer of food, agricultural, financial and industrial products and services.
More informationISPE Annual Meeting 29 October 1 November 2017 San Diego, CA. FDA Perspective on the Use of Process Capability
FDA Perspective on the Use of Process Capability Chunsheng Cai, Ph.D. Office of Process and Facilities Office of Pharmaceutical Quality, CDER, FDA 2017 ISPE Annual Meeting & Expo Disclaimer This presentation
More informationThe call to action for digital transformation. Uwe Kueppers Senior Business Consultant Rockwell Automation Chairman MESA EMEA
The call to action for digital transformation Uwe Kueppers Senior Business Consultant Rockwell Automation Chairman MESA EMEA What If... Teams are dynamic getting together and solve things! People are transforming
More informationLatino America Consultores Innovation & Technology to make your Business Compliant
Latino America Consultores Innovation & Technology to make your Business Compliant Annex 15 & EMA Process Validation Guide Line 1 Changes in Requirements The Pharmaceutical Industry has adapted its business
More informationtempris sensor Tempris a powerful PAT Tool Pave your way to Pharma 4.0 with
tempris sensor technology Pave your way to Pharma 4.0 with Tempris a powerful PAT Tool process control with wireless, battery-free real-time temperature measurement WHY USE TEMPRIS as a PAT Tool for product
More informationPAT for the On-line Characterization of Continuous Manufacturing Systems
PAT for the On-line Characterization of Continuous Manufacturing Systems Thomas O Connor, Ph.D. Office of Pharmaceutical Science FDA/PQRI Conference: Innovation in Manufacturing and Regulatory Assessment
More information1. Master Batch Record Approvals Name Signature Date Originator
Effective: Page 1 of 17 1. Master Approvals Name Signature Date Originator Ravikanth Kona Production Ravikanth Kona Quality Control Seon Hepburn Stephen Hoag Quality Assurance 2. Product Details Description
More informationIndustry Digitizing the Shop Floor to Achieve Operational Excellence & Customer Successes
Industry 4.0 - Digitizing the Shop Floor to Achieve Operational Excellence & Customer Successes Raj Singh Director Operational Excellence IOT & Digital Supply Chain - Center of Excellence Agenda Introduction
More informationLifecycle Product Quality Risk Management
Lifecycle Product Quality Risk Management Richard L. Friedman, M.S. Associate Director Office of Manufacturing and Product Quality Office of Compliance IFPAC Annual Meeting (Arlington, VA) January, 21-24,
More informationDesigning Batch Systems for e-manufacturing
Presented at the World Batch Forum North American Conference Orlando, Florida April 2001 107 S. Southgate Drive Chandler, Arizona 85226-3222 480-893-8803 Fax 480-893-7775 E-mail: info@wbf.org www.wbf.org
More informationLife-science companies have
FOCUS ON... INFORMATION TECHNOLOGY Building an Electronic Batch Record System Part 1: Fitting into an Existing Software Environment by Ronald R. Davenhall Life-science companies have always put significant
More informationSAP Digital Manufacturing Strategy
SAP Digital Manufacturing Strategy Carlos Portillo EMEA Center of Excellence Digital Supply Chain Industry 4.0, Manufacturing, Asset Management & Sustainability Agenda Time Duration Topic Speaker 09:30
More informationInnovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series
CAMO European Pharmaceutical Seminars Jan/Feb 2009 Innovative Approaches to Pharmaceutical Development and Manufacturing Seminar Series The Increasing Need of Multivariate Analysis for Process Understanding
More informationProcess Validation Guidelines. Report highlights 23 rd February 2018
Process Validation Guidelines Report highlights 23 rd February 2018 Process validation is an important element of pharmaceutical quality system An effective system provides assurance of the continued capability
More informationReal-time tablet API analysis: a comparison of a palm-size NIR spectrometer to HPLC method
Real-time tablet API analysis: a comparison of a palm-size NIR spectrometer to HPLC method Presented by: Chris Pederson, Product Applications Engineer, JDS Uniphase Corp. Co-Authors: Nada O Brien, JDS
More informationStage 3 - Process Validation: Measuring what matters
Stage 3 - Process Validation: Measuring what matters Trevor Schoerie - PharmOut A quote. The company that fails is the company that comes to us and says Just tell us what to do and we will do it. The company
More informationQuality by Design, Revolution or Evolution? Wim Oostra
Quality by Design, Revolution or Evolution? Wim Oostra 1993 1998 2007 2009 2013 And many more.. Content Introduction A bit of history Examples A New product Legacy product Today? The triggers The goal
More informationValidation of Pharmaceutical Manufacturing Process Focus: APIs.
Validation of Pharmaceutical Manufacturing Process Focus: APIs Validations: Regulatory History (US FDA) Sterilisation 1977 Aseptic processing 1979 Water Systems 1981 Non-sterile Mfg Process 1987 Revised
More informationPAT: Impacting Manufacturing Operations & Automation Platforms From Procedural to Risk-based Compliance, Inspection, and Enforcement
PAT: Impacting Manufacturing Operations & Automation Platforms From Procedural to Risk-based Compliance, Inspection, and Enforcement John Blanchard ARC Advisory Group jblanchard@arcweb.com What is PAT?
More informationLifecycle Management of Process Analytical Technology Procedures
Lifecycle Management of Process Analytical Technology Procedures IFPAC 2015 Marta Lichtig Senior Scientist in New Testing Technologies, ACS Member Contents General Comparison : PV guide to NIR model development
More informationSIMATIC IT ebr 6.1SP1
SIMATIC IT ebr 6.1SP1 www.siemens.com/simatic-it Release of SIMATIC IT ebr 6.1 SP1 (December 2016) SIMATIC IT ebr 6.1 SP1 is the latest software update of the Siemens MES solution for electronic batch
More informationED16 - Maintain Data Continuity When Networks Fail with FactoryTalk Historian Machine Edition
ED16 - Maintain Data Continuity When Networks Fail with FactoryTalk Historian Machine Edition Timothy J McCain Information Software Regional Manager November 2012 ED16 FactoryTalk Historian Machine Edition
More informationProcess Analytical Technology (PAT) / Quality by Design (QbD): Integrated Systems in the Future Pharma Business Landscape
Process Analytical Technology (PAT) / Quality by Design (QbD): Integrated Systems in the Future Pharma Business Landscape Glenn Restivo Industry Manager Life Sciences Siemens Center of Competence Sept
More informationOptimal alignment between Processes, Organisation & Technology. Senior Specialist Leif Poulsen, MSc, PhD, Automation & IT, NNE Pharmaplan A/S
Optimal alignment between Processes, Organisation Technology Senior Specialist Leif Poulsen, MSc, PhD, Automation IT, NNE Pharmaplan A/S Agenda Business Objectives Means Process Understanding is Key Roles
More informationQuality by Design for Drug Products. Dr. Lorenz Liesum Global Technical Operation, Novartis Swiss Association for Quality Meeting , Olten
Quality by Design for Drug Products Dr. Lorenz Liesum Global Technical Operation, Novartis Swiss Association for Quality Meeting 04-03-2010, Olten Overview QbD/PAT Concept QbD/PAT Toolbox DoEs PAT Methods
More informationCombining Laboratory and Process Data on the PI System. Copyright 2013 OSIsoft, LLC.
Combining Laboratory and Process Data on the PI System Presented by Kevin Crean Kevin Crean Automation and Control Engineer Manufacturing Systems - Janssen Pharmaceutical 2 Agenda Introduction Janssen
More informationUSING OPERATIONAL EXCELLENCE (OPEX) AND LEAN MANAGEMENT TO IMPROVE ORGANIZATIONAL INTELLIGENCE
PHARMATALK 11 TH MAY 2015 BERLIN USING OPERATIONAL EXCELLENCE (OPEX) AND LEAN MANAGEMENT TO IMPROVE ORGANIZATIONAL INTELLIGENCE Dr. Joerg Tautrim Strategic Lean consultant, Director Lean Institute Germany
More informationInt. J. Pharm. Sci. Rev. Res., 34(1), September October 2015; Article No. 23, Pages: Process Validation of Tablet Dosage Form in Industries
Review Article Process Validation of Tablet Dosage Form in Industries Ram Mohan S.R, N. Vishal Gupta* Pharmaceutical Quality Assurance group, Dept of Pharmaceutics, JSS University, Sri ShivarathreeshwaraNagara,
More informationPrequalification Team Inspection services WHO INSPECTION REPORT of the FPP manufacturer
Prequalification Team Inspection services WHO INSPECTION REPORT of the FPP manufacturer Part 1 Manufacturers details Company information Name of manufacturer Corporate address of manufacturer Contact person
More informationPAT/QbD Bringing Pharma into the 21 st Century. Creating Innovations for the Pharmaceutical Industry. usa.siemens.com/pharma
PAT/QbD Bringing Pharma into the 21 st Century Creating Innovations for the Pharmaceutical Industry usa.siemens.com/pharma The pharmaceutical industry is headed for fundamental changes within the next
More informationApplication of Quality by Design (QbD) in product development. James E. Polli September 16, 2015
Application of Quality by Design (QbD) in product development James E. Polli jpolli@rx.umaryland.edu September 16, 2015 Pharmaceutical Equivalence Same active ingredient(s) Same dosage form Same route
More informationHealth Authority Inspection Management. GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012
Health Authority Inspection Management GMP Inspection practices L. Mansolelli, Group Compliance & Auditing June 2012 Abstract As global health authorities align in inspection standards and practices, key
More informationGoing Paperless Baxter MD - Full electronic Batch Record & Release with XFP SIMATIC IT. Answers for industry.
Going Paperless Baxter MD - Full electronic Batch Record & Release with XFP SIMATIC IT Answers for industry. Before we implemented XFP-MES at the Irish plant, the documentation department needed 3 to 4
More informationBenefits. + + Consistent quality to recipe specification. + + Increase asset utilization and operational efficiency
Wonderware InBatch Flexible Batch Management Wonderware InBatch software enables sophisticated equipment arbitration and concurrent batch execution capabilities to maximize asset utilization, plant throughput
More informationBenefits of a Standardized PI System
Benefits of a Standardized PI System Presented by Axel Wils Agenda Introduction Standardized Content, Execution & Visualization Real Examples Other Focus Areas Next Steps 2 What is SPIRIT? Standardize
More informationSynopsis: FDA Process Validation Guidance
Synopsis: FDA Process Validation Guidance This synopsis is a comparison of the draft version 2008 and the final version 2011 of the U.S. FDA Guidance Process Validation: General Principles and Practices.
More informationValidation of MES and Manufacturing Automation systems
Validation of MES and Manufacturing Automation systems The FDA Group Presentation APRIL 26, 2017 Chinmoy Roy, B.S. (Hons.) MSCS Industry Consultant 1 Agenda What is a MES Validation concepts Validation
More informationSolution for Manufacturing Flexibility and Efficiency. Business Intelligence. Chatchai Wajakiet / Chee Hoe Lee
Solution for Manufacturing Flexibility and Efficiency Business Intelligence Chatchai Wajakiet / Chee Hoe Lee Copyright 2009 Rockwell Automation, Inc. All rights reserved. Agenda 1. Basic Manufacturing
More informationContinuous manufacturing moving towards real-time release. Creating innovations for the pharmaceutical industry. siemens.
Continuous manufacturing moving towards real-time release Creating innovations for the pharmaceutical industry siemens.com/pharma Strategic partnership Creative ideas and industry expertise A move to continuous
More informationCIM and Business Processes
CIM and Business Processes Agenda n Introduction n Computer Integrated Manufacturing n ANSI ISA 95 n Examples of CIM levels n CIM and data communication n Conclusions Introduction n This lesson will provide
More informationOverview of Regulatory Requirements for API and Formulations
Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed
More informationPreparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014
Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls
More informationTablet formulation design spaces for direct compression and roller compaction. QbD in Pharmaceutical Development: processes
QbD in Pharmaceutical Development: Tablet formulation design spaces for direct compression and roller compaction processes Morten Allesø, PhD (MSc Pharm) Pharmaceutical scientist ISPE Nordic PAT CoP, June
More information2nd FDA/PQRI Conference on Advancing Product Quality
2nd FDA/PQRI Conference on Advancing Product Quality Generic Pharma Perspective on the Identification of Critical Quality Attributes and Critical Process Parameters Bruce D. Johnson, Ph.D. Vice President
More information